CRN statement in response to FDA Commissioner Robert Califf's recent remarks at the NIH-FDA Nutrition Regulatory Workshop
Commissioner Califf’s call for premarket evaluation of dietary supplements and his assertion that there is “very little evidence” supporting these products reflect a fundamental misunderstanding of DSHEA